| Literature DB >> 30905349 |
Myungsun Shin1, Timothy B Ware1, Hyeon-Cheol Lee2, Ku-Lung Hsu3.
Abstract
The metabolic serine hydrolases hydrolyze ester, amide, or thioester bonds found in broad small molecule substrates using a conserved activated serine nucleophile. The mammalian central nervous system (CNS) express a diverse repertoire of serine hydrolases that act as (phospho)lipases or lipid amidases to regulate lipid metabolism and signaling vital for normal neurocognitive function and CNS integrity. Advances in genomic DNA sequencing have provided evidence for the role of these lipid-metabolizing serine hydrolases in neurologic, psychiatric, and neurodegenerative disorders. This review briefly summarizes recent progress in understanding the biochemical and (patho)physiological roles of these lipid-metabolizing serine hydrolases in the mammalian CNS with a focus on serine hydrolases involved in the endocannabinoid system. The development and application of specific inhibitors for an individual serine hydrolase, if available, are also described. This article is part of a Special Issue entitled Novel functions of phospholipase A2 Guest Editors: Makoto Murakami and Gerard Lambeau.Entities:
Keywords: 2‑Arachidonoylglycerol; Activity-based protein profiling (ABPP); Anandamide; Endocannabinoid; Phospholipase; Serine hydrolase
Mesh:
Substances:
Year: 2018 PMID: 30905349 PMCID: PMC6433413 DOI: 10.1016/j.bbalip.2018.08.007
Source DB: PubMed Journal: Biochim Biophys Acta Mol Cell Biol Lipids ISSN: 1388-1981 Impact factor: 4.698